We found no effect of the ATM or ERBB2 tagSNPs (supplementary Table 5) or haplotypes (supplementary Table 6) on the overall risk of breast cancer, which was not altered after conditioning on the selection variables (menopausal hormone therapy and diabetes mellitus) or restricting the analyses to the randomly selected cases and controls. This evidence concerns the gene ERBB2 and breast cancer.